ArticleCardiology and therapy2026

Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children.

Sebastiano A G Lava et al.PubMed ↗Publisher ↗

No numbers read from the abstract.